These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17526088

  • 1. Prevention of death in COPD.
    La Vecchia C, Fabbri LM.
    N Engl J Med; 2007 May 24; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
    Hackam DG.
    CMAJ; 2003 May 13; 168(10):1296-7. PubMed ID: 12743078
    [No Abstract] [Full Text] [Related]

  • 7. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec 13; 16(92):257-8. PubMed ID: 18092426
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 13; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 10. Assessing mortality risk in COPD.
    Richie RC.
    J Insur Med; 2008 Dec 13; 40(1):55-63. PubMed ID: 18924368
    [No Abstract] [Full Text] [Related]

  • 11. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

  • 12. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
    Doherty DE, Chapman KR, Martinez FJ, Belfer MH.
    J Fam Pract; 2007 Oct 10; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
    [No Abstract] [Full Text] [Related]

  • 13. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
    Johnson M, Agusti AG, Barnes NC.
    COPD; 2008 Dec 10; 5(6):369-75. PubMed ID: 19353351
    [Abstract] [Full Text] [Related]

  • 14. Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.
    Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC, Jones PW.
    Clin Respir J; 2011 Jan 10; 5(1):44-9. PubMed ID: 21159140
    [Abstract] [Full Text] [Related]

  • 15. Combined salmeterol and fluticasone for COPD.
    Khamis RY, Rajakulasingam RK.
    Lancet; 2003 May 10; 361(9369):1652; author reply 1652-3. PubMed ID: 12747905
    [No Abstract] [Full Text] [Related]

  • 16. Choice of bronchodilator therapy for patients with COPD.
    Wedzicha JA.
    N Engl J Med; 2011 Mar 24; 364(12):1167-8. PubMed ID: 21428773
    [No Abstract] [Full Text] [Related]

  • 17. [Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group.
    Rev Port Pneumol; 2005 Mar 24; 11(6):587-9. PubMed ID: 16514718
    [No Abstract] [Full Text] [Related]

  • 18. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 24; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 19. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):322-3. PubMed ID: 18676961
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
    Clin Ther; 2007 Jun 15; 29(6):1203-13. PubMed ID: 17692734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.